Product
BBI-5000
1 clinical trial
2 indications
Indication
DermatitisIndication
AtopicClinical trial
An Open-Label, Single-Dose, 4-Way Crossover, Bioavailability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Food Effect of BBI-5000 Capsules in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2015-12-01